Cargando…

Computational Fluid Dynamics Modeling of Liver Radioembolization: A Review

Yttrium-90 radioembolization (RE) is a widely used transcatheter intraarterial therapy for patients with unresectable liver cancer. In the last decade, computer simulations of hepatic artery hemodynamics during RE have been performed with the aim of better understanding and improving the therapy. In...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aramburu, Jorge, Antón, Raúl, Rodríguez-Fraile, Macarena, Sangro, Bruno, Bilbao, José Ignacio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716346/ https://www.ncbi.nlm.nih.gov/pubmed/34518913 http://dx.doi.org/10.1007/s00270-021-02956-5

Ejemplares similares

A proof-of-concept study of the in-vivo validation of a computational fluid dynamics model of personalized radioembolization
por: Antón, Raúl, et al.
Publicado: (2021)

Computational study of a novel catheter for liver radioembolization
por: Ortega, Julio, et al.
Publicado: (2022)

The joint use of (99m)Tc-MAA-SPECT/CT and cone-beam CT optimizes radioembolization planning
por: Rodríguez-Fraile, Macarena, et al.
Publicado: (2021)

Pure laparoscopic major liver resection after yttrium(90) radioembolization: a case-matched series analysis of feasibility and outcomes
por: Aliseda, Daniel, et al.
Publicado: (2022)

Liver Resection and Transplantation Following Yttrium-90 Radioembolization for Primary Malignant Liver Tumors: A 15-Year Single-Center Experience
por: Aliseda, Daniel, et al.
Publicado: (2023)

In Vitro Model for Simulating Drug Delivery during Balloon-Occluded Transarterial Chemoembolization
por: Aramburu, Jorge, et al.
Publicado: (2021)

Clinical Application of Radioembolization in Hepatic Malignancies: Protocol for a Prospective Multicenter Observational Study
por: Helmberger, Thomas, et al.
Publicado: (2020)

A new animal model of atrophy–hypertrophy complex and liver damage following Yttrium-90 lobar selective internal radiation therapy in rabbits
por: Páramo, María, et al.
Publicado: (2022)

Short-term Safety and Quality of Life Outcomes Following Radioembolization in Primary and Secondary Liver Tumours: a Multi-centre Analysis of 200 Patients in France
por: Loffroy, Romaric, et al.
Publicado: (2020)

Radioembolization versus chemoembolization for unresectable hepatocellular carcinoma: a meta-analysis of randomized trials
por: Gardini, Andrea Casadei, et al.
Publicado: (2018)

Radioembolization treatment for liver metastases
por: Kiszkaą, Joanna, et al.
Publicado: (2017)

Clinical Application of Trans-Arterial Radioembolization in Hepatic Malignancies in Europe: First Results from the Prospective Multicentre Observational Study CIRSE Registry for SIR-Spheres Therapy (CIRT)
por: Helmberger, Thomas, et al.
Publicado: (2020)

Prognostic value of baseline interleukin 6 levels in liver decompensation and survival in HCC patients undergoing radioembolization
por: Öcal, Osman, et al.
Publicado: (2021)

A Supramolecular Approach for Liver Radioembolization
por: Spa, Silvia J., et al.
Publicado: (2018)

Repeated radioembolization in advanced liver cancer
por: Masthoff, Max, et al.
Publicado: (2020)

Evaluation of the rabbit liver by direct portography and contrast-enhanced computed tomography: anatomical variations of the portal system and hepatic volume quantification
por: Páramo, María, et al.
Publicado: (2017)

Predictive Factors for Adverse Event Outcomes After Transarterial Radioembolization with Yttrium-90 Resin Microspheres in Europe: Results from the Prospective Observational CIRT Study
por: Maleux, Geert, et al.
Publicado: (2023)

Radioembolization in the Treatment of Neuroendocrine Tumor Metastases to the Liver
por: Vyleta, Martin, et al.
Publicado: (2011)

Hepatic Radioembolization as a Bridge to Liver Surgery
por: Braat, Arthur J. A. T., et al.
Publicado: (2014)

Impact of the dosimetry approach on the resulting (90)Y radioembolization planned absorbed doses based on (99m)Tc-MAA SPECT-CT: is there agreement between dosimetry methods?
por: Morán, Verónica, et al.
Publicado: (2020)

The physics of radioembolization
por: Bastiaannet, Remco, et al.
Publicado: (2018)

The Evolving Role of Radioembolization in the Treatment of Neuroendocrine Liver Metastases
por: Ramdhani, Khalil, et al.
Publicado: (2022)

Radioembolization and the Dynamic Role of (90)Y PET/CT
por: Pasciak, Alexander S., et al.
Publicado: (2014)

Transarterial radioembolization for liver tumors as neoadjuvant therapy: three case reports
por: Carvalho, Vithor de Oliveira, et al.
Publicado: (2020)

Selective internal radiation therapy: an effective treatment for hormonal syndromes in pancreatic neuroendocrine tumors
por: Zubiri, Leyre, et al.
Publicado: (2018)

Multimodal image registration for liver radioembolization planning and patient assessment
por: Spahr, Nadine, et al.
Publicado: (2018)

Microspheres Used in Liver Radioembolization: From Conception to Clinical Effects
por: d’Abadie, Philippe, et al.
Publicado: (2021)

Automatic healthy liver segmentation for holmium-166 radioembolization dosimetry
por: Stella, Martina, et al.
Publicado: (2023)

Dynamic Lymphocyte Changes Following Transarterial Radioembolization: Association with Normal Liver Dose and Effect on Overall Survival
por: Young, Shamar, et al.
Publicado: (2022)

Hepatobiliary Scintigraphy and Glass (90)Y Radioembolization with Personalized Dosimetry: Dynamic Changes in Treated and Nontreated Liver
por: Allimant, Carole, et al.
Publicado: (2021)

Factors impacting survival after transarterial radioembolization in patients with hepatocellular carcinoma: Results from the prospective CIRT study
por: Kolligs, Frank, et al.
Publicado: (2022)

Mode of progression after radioembolization in patients with colorectal cancer liver metastases
por: van Roekel, Caren, et al.
Publicado: (2020)

Quality of life in patients with liver tumors treated with holmium-166 radioembolization
por: van Roekel, Caren, et al.
Publicado: (2019)

Gamma camera characterization at high holmium-166 activity in liver radioembolization
por: Stella, Martina, et al.
Publicado: (2021)

Analysis of failed therapy evaluations in radioembolization of primary and secondary liver cancers
por: Masthoff, Max, et al.
Publicado: (2020)

Impact of Pharmaceutical Prophylaxis on Radiation-Induced Liver Disease Following Radioembolization
por: Seidensticker, Max, et al.
Publicado: (2021)

Diagnostic Performance of Theranostic Radionuclides Used in Transarterial Radioembolization for Liver Cancer
por: Li, Rou, et al.
Publicado: (2021)

Economic evaluations of radioembolization with yttrium-90 microspheres in liver metastases of colorectal cancer: a systematic review
por: Alonso, JC, et al.
Publicado: (2023)

Nivolumab after selective internal radiation therapy for the treatment of hepatocellular carcinoma: a phase 2, single-arm study
por: de la Torre-Aláez, Manuel, et al.
Publicado: (2022)

Radioembolization for the treatment of hepatocellular carcinoma
por: Kim, Hyo-Cheol
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1213i0suhbrmqsgjqhpohamc44